Bhargavi Pandit Rph

Bhargavi Pandit RPh, MS, RAC is an experienced regulatory affairs professional with a focus on oncology. Currently serving as Executive Director of Global Regulatory and Labeling Strategy at Karyopharm Therapeutics Inc., Bhargavi has previously held senior positions at AstraZeneca, Boehringer Ingelheim, GSK, and SUN PHARMA, progressing through the ranks from Regulatory Affairs Associate to Director roles. Educational accomplishments include a certificate in Business Strategy from Harvard Business School and a role on the Board of Editors for RAPS from 2016 to 2018.